Xaracoll
Active Ingredient(s): Bupivacaine HciFDA Approved: * August 28, 2020
Pharm Company: * INNOCOLL PHARMACEUTICALS
Category: Anesthetic
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Xaracoll Overview
Bupivacaine, marketed under the brand name Marcaine among others, is a medication used to decrease feeling in a specific area.[1] In nerve blocks, it is injected around a nerve that supplies the area, or into the spinal canal's epidural space.[1] It is available mixed with a small amount of epinephrine to increase the duration of its action.[1] It typically begins working within 15 minutes and lasts for 2 to 8 hours.[1][2...
Read more Xaracoll DetailsDetails May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bupivacaine
Recent Xaracoll Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Bupivacaine Hci
- Implant: 300mg
- Injection: 0.25%, 0.25% + 0.0091mg/ml, 0.5%, 0.5% + 0.0091mg/ml, 0.50%, 0.75%, 0.75% + 0.0091mg/ml, 106mg, 266mg
- Injection, Liposomal: 133mg/10ml (13.3mg/ml), 266mg/20ml (13.3mg/ml)
Other drugs which contain Bupivacaine Hci or a similar ingredient: (7 results)
- BUPIVACAINE 1 discussion
- BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE Bupivacaine Hydrochloride
- EXPAREL Bupivacaine Liposome
- MARCAINE Bupivacaine2 discussions
- MARCAINE SPINAL Bupivacaine
- SENSORCAINE Bupivacaine
- SENSORCAINE-MPF Bupivacaine